• Yuichi Ikuyama, Yosuke Wada, Kazunari Tateishi, Yoshiaki Kitaguchi, Masanori Yasuo, Atsuhito Ushiki, Kazuhisa Urushihata, Hiroshi Yamamoto, Hiroshi Kamijo, Atsuyoshi Mita, Hiroshi Imamura, and Masayuki Hanaoka.
• First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
• Respir Med Case Rep. 2020 Jan 1; 30: 101113.

AbstractA public health emergency of current international concern is the outbreak of a severe respiratory illness, that is, coronavirus disease (COVID-19). The disease initially started in Wuhan, China, and it rapidly spread to most regions of the world. Herein, we report a case of critical COVID-19 pneumonia treated with extracorporeal membrane oxygenation from symptom onset day 19 (SOD#19) to SOD#30. We describe the patient's clinical course, from mild symptoms at the time of illness onset to symptoms of severe pneumonia as the illness progressed. We provide important information regarding our clinical experience for further understanding of management discrepancies, as treatment with extracorporeal membrane oxygenation or pharmacotherapy (e.g., antivirals, immunomodulators, and glucocorticoids) is often dependent on the severity of symptoms.© 2020 The Authors.

7 keywords...

hide…